Pre-clinical commercialization of a synthetically designed, live-attenuated RSV vaccine
Ended Project Grant Awarded Last action
- Award ID
- R44AI131756
- Recipient
-
Codagenix Inc. UEI TEMNL437K2F1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,562,475
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $809,351 | |
| Amendment | $809,351 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,716,496 | |
| Amendment | $727,278 | |
| Amendment | $0 | |
| Amendment | $744,622 | |
| Original award | $755,377 |
Show all 16
Quick answers
Who received award R44AI131756?
R44AI131756 was awarded to Codagenix Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 16, 2017.
How much is award R44AI131756 worth?
$5,562,475 has been obligated on R44AI131756.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award